|
Lipid Gb3 as an adjuvant for anti-viral vaccination
Lipid Gb3 as adjuvant for anti-viral vaccination
Background
Adjuvants are vaccine components added to enhance the magnitude, breadth, and durability of response.
Selection of appropriate adjuvants requires improved understanding of immune responses to pathogens/antigens by B cells (white blood cells). B cells develop in the bone marrow and are...
Published: 3/23/2026
|
Updated: 1/12/2024
|
Inventor(s): Florian Winau, Pankaj Sharma
Keywords(s): Adjuvants, Immunology
Category(s): Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Invention Type > Vaccines > Adjuvants
|
